EUVIMEDEUVIMED entdecken
Open Access

Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors

Yulu Chen iD, Antonio Checa, Pei Zhang, Mengna Huang, Rachel S Kelly iD, Min Kim iD, Yih-Chieh S Chen, Kathleen A Lee-Sarwar, Nicole Prince, Kevin M Mendez, Sofina Begum, Priyadarshini Kachroo und 9 weitere

Allergy · 2024

DOI: 10.1111/all.15942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Yulu Chen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Sphingolipids, Asthma. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, European Research Council, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While dysregulated sphingolipid metabolism has been associated with risk of childhood asthma, the specific sphingolipid classes and/or mechanisms driving this relationship remain unclear. We aimed to understand the multifaceted role between sphingolipids and other established asthma risk factors that complicate this relationship. Method s We performed targeted LC–MS/MS‐based quantification of 77 sphingolipids in plasma from 997 children aged 6 years from two independent cohorts (VDAART and COPSAC 2010 ). We examined associations of circulatory sphingolipids with childhood asthma, lung function, and three asthma risk factors: functional SNPs in ORMDL3 , low vitamin D levels, and reduced gut microbial maturity. Given racial differences between these cohorts, association analyses were performed separately and then meta‐analyzed together.

Results

We observed elevations in circulatory sphingolipids with asthma phenotypes and risk factors; however, there were differential associations of sphingolipid classes with clinical outcomes and/or risk factors. While elevations from metabolites involved in ceramide recycling and catabolic pathways were associated with asthma and worse lung function [meta p ‐value range: 1.863E‐04 to 2.24E‐3], increased ceramide levels were associated with asthma risk factors [meta p ‐value range: 7.75E‐5 to .013], but not asthma. Further investigation identified that some ceramides acted as mediators while some interacted with risk factors in the associations with asthma outcomes.

Conclusion

This study demonstrates the differential role that sphingolipid subclasses may play in asthma and its risk factors. While overall elevations in sphingolipids appeared to be deleterious overall; elevations in ceramides were uniquely associated with increases in asthma risk factors only; while elevations in asthma phenotypes were associated with recycling sphingolipids. Modification of asthma risk factors may play an important role in regulating sphingolipid homeostasis via ceramides to affect asthma. Further function work may validate the observed associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingolipidsAsthmaChildHumansChromatography, LiquidTandem Mass SpectrometryCeramidesRisk Factors

Stichwörter der Autor:innen

asthma risk factorschildhood asthmalung functionmetabolomic epidemiologysphingolipids

Substanzen

SphingolipidsCeramides

Autor:innen und Institutionen

  • Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
  • Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
  • Gunma University Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Gunma, Japan.
  • Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Herlev and Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.
  • Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Yulu Chen, Rachel S Kelly, Min Kim, Jakob Stokholm, Hans Bisgaard, Bo L Chawes

Förderung

  • NHLBI NIH HHS
  • European Research Council
  • NIAID NIH HHS
  • NIEHS NIH HHS
  • Japan Society for the Promotion of Science
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Chen, Y., Checa, A., Zhang, P., Huang, M., Kelly, R. S., Kim, M., Chen, Y. S., Lee-Sarwar, K. A., Prince, N., Mendez, K. M., Begum, S., Kachroo, P., Chu, S. H., Stokholm, J., Bønnelykke, K., Litonjua, A. A., Bisgaard, H., Weiss, S. T., Chawes, B. L., …, & Lasky-Su, J. A. (2024). Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors. Allergy. https://doi.org/10.1111/all.15942

Vancouver

Chen Y, Checa A, Zhang P, Huang M, Kelly RS, Kim M, et al. Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors. Allergy. 2024. doi:10.1111/all.15942

BibTeX
@article{Chen2024,
  author = {Chen, Yulu and Checa, Antonio and Zhang, Pei and Huang, Mengna and Kelly, Rachel S and Kim, Min and Chen, Yih-Chieh S and Lee-Sarwar, Kathleen A and Prince, Nicole and Mendez, Kevin M and Begum, Sofina and Kachroo, Priyadarshini and Chu, Su H and Stokholm, Jakob and Bønnelykke, Klaus and Litonjua, Augusto A and Bisgaard, Hans and Weiss, Scott T and Chawes, Bo L and Wheelock, Craig E and Lasky-Su, Jessica A},
  title = {Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.15942}
}
Kostenlos starten →